[1] DeSantis C,Siegel R,Bandi P,et al. Breast cancer statistics,2011[J].CA Cancer J Clin,2011,61(6):409-418. [2] Lara-Guerra H,Roth JA.Gene therapy for lung cancer[J].Crit Rev Oncog,2016,21(1/2):115-124. [3] Wang X,Zhou P,Sun X,et al.Modification of the hTERT promoter by heat shock elements enhances the efficiency and specificity of cancer targeted gene therapy[J].Int J Hyperthermia,2016,32(3):244-253. [4] Okino ST,Chichester CH,Whitlock JP Jr.Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter and at an initiator-driven promoter[J].J Biol Chem,2004,273(37):23837-23843. [5] Kwon OJ,Kim PH,Huyn S,et al.A hypoxia-and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas[J].Clin Cancer Res,2010,16(24):6071-6082. [6] Liu LL,Smith MJ,Sun BS,et al.Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model[J].Ann Surg Oncol,2009,16(5):1403-1411. [7] Li Y,Guo C,Wang Z,et al.Enhanced effectes of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth,promoting apoptosis and inducing cell cycle arrest in vascular endothelial cells[J].J Huazhong Univ Sci Technolog Med Sci,2012,32(2):167-172. [8] Pluta P,Cebula-Obrzut B,Ehemann V,et al.Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients[J].Neoplasma,2011,58(5):430-435. [9] 王宏芳,吴嘉慧,刘纯岩,等.携带TRAIL基因的条件复制型腺病毒载体的构建及其辐射诱导表达[J].吉林大学学报:医学版,2014,40(4):699-704. [10] Yang SW,Chanda D,Cody JJ,et al.Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer[J].PLoS One,2011,6(10):e25131. [11] Zheng FQ,Xu Y,Yang RJ,et al.Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models[J].Acta Pharmacol Sin,2009,30(5):617-627. [12] Senzer N,Mani S,Rosemurgy A,et al.TNFerade biologic,an adenovector with a radiation-inducible promoter,carrying the human tumor necrosis factor alpha gene:a phase Ⅰ study in patients with solid tumors[J].J Clin Oncol,2004,22(4):592-601. [13] Anguiano-Hernandez YM,Chartier A,Huerta S.Smac/DIABLO and colon cancer[J].Anticancer Agents Med Chem,2007,7(4):467-473. [14] Ledgerwood EC,Morison IM.Targeting the apoptosome for cancer therapy[J].Clin Cancer Res,2009,15(2):420-424. [15] Fandy TE,Shankar S,Srivastava RK.Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation,and sensitizes TRAIL-resistant breast cancer cells[J].Mol Cancer,2008,7:60. [16] Deplanque G,Céraline J,Mah-Becherel MC,et al.Caffeine and the G2/M block override:a concept resulting from a misleading cell kinetic delay,independent of functional p53[J].Int J Cancer,2001,94(3):363-369. |